Authors: Frantsve, J Schwaller, J Sternberg, DW Kutok, J Gilliland, DG

Citation: J. Frantsve et al., Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation, MOL CELL B, 21(10), 2001, pp. 3547-3557

Authors: Sternberg, DW Tomasson, MH Carroll, M Curley, DP Barker, G Caprio, M Wilbanks, A Kazlauskas, A Gilliland, DG

Citation: Dw. Sternberg et al., The TEL/PDGF beta R fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways, BLOOD, 98(12), 2001, pp. 3390-3397

Authors: Schwaller, J Anastasiadou, E Cain, D Kutok, J Wojiski, S Williams, IR LaStarza, R Crescenzi, B Sternberg, DW Andreasson, P Schiavo, R Siena, S Mecucci, C Gilliland, DG

Citation: J. Schwaller et al., H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22), BLOOD, 97(12), 2001, pp. 3910-3918

Authors: Tomasson, MH Sternberg, DW Williams, IR Carroll, M Cain, D Aster, JC Ilaria, RL Van Etten, RA Gilliland, DG

Citation: Mh. Tomasson et al., Fatal myeloproliferation, induced in mice by TEL/PDGF beta R expression, depends on PDGF beta R tyrosines 579/581, J CLIN INV, 105(4), 2000, pp. 423-432

Authors: Sternberg, DW Aird, W Neuberg, D Thompson, L MacNeill, K Amrein, P Shulman, LN

Citation: Dw. Sternberg et al., Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine - A pharmacologically based regimen, CANCER, 88(9), 2000, pp. 2037-2041